JSPR
Jasper Therapeutics Inc
0.5854$
+3.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.3% | 93.7% | 95.5% | 95.4% | 95.4% | 94.9% | 92.3% | 92.5% | 94.9% | 96.8% | 95.8% | 98.0% | |
| 94.1% | 91.6% | 94.1% | 93.8% | 93.0% | 89.7% | 84.7% | 85.0% | 88.6% | 80.2% | 66.8% | 62.0% | |
| 94.1% | 91.6% | 94.1% | 93.8% | 93.0% | 89.7% | 84.7% | 85.0% | 88.6% | 80.2% | 66.8% | 62.0% | |
| 0.2% | 0.3% | 0.2% | 0.2% | 0.3% | – | – | – | – | – | – | – | |
| 0.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 14.7% | 17.3% | 10.1% | 12.0% | 15.8% | 22.8% | 26.7% | 49.4% | 79.9% | 88.4% | 84.0% | 88.0% | |
| 10.8% | 13.0% | 7.1% | 8.8% | 12.5% | 19.1% | 21.4% | 44.1% | 36.6% | 36.9% | 42.5% | 66.5% | |
| 0.9% | 1.0% | 0.8% | 0.9% | 1.1% | 1.4% | 3.2% | 4.2% | 3.0% | 3.5% | 3.6% | 2.3% | |
| 2.9% | 4.4% | 1.9% | 2.6% | 3.1% | 5.0% | 5.2% | 17.3% | 15.9% | 17.4% | 11.5% | 23.5% | |
| 85.3% | 82.7% | 89.9% | 88.0% | 84.2% | 77.2% | 73.3% | 50.6% | 20.1% | 11.6% | 16.0% | 12.0% | |
| -138.6% | -178.7% | -145.5% | -173.7% | -217.8% | -301.5% | -455.1% | -621.6% | -535.2% | -885.1% | -1,500.4% | -2,716.5% | |
| 9.9% | 11.6% | 10.6% | 13.2% | 15.1% | 18.8% | 26.1% | 33.0% | 28.9% | 80.1% | 135.3% | 243.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.